Raphael Pharmaceutical (RAPH) Share-based Compensation (2022 - 2025)

Raphael Pharmaceutical has disclosed Share-based Compensation across 3 years of filings, most recently posting $1000.0 for Q4 2025.

• In Q4 2025, Share-based Compensation fell 99.65% year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $245000.0 (down 89.3% YoY), while the FY2025 annual figure was $245000.0, down 30.0% from the prior year.
• Share-based Compensation came in at $1000.0 for Q4 2025 at Raphael Pharmaceutical, down from $39000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q3 2022 to a low of $1000.0 in Q4 2025.
• Average Share-based Compensation over 3 years is $313777.8, with a median of $150000.0 recorded in 2022.
• The largest YoY upside for Share-based Compensation was 99.65% in 2025 against a maximum downside of 99.65% in 2025.
• Over 3 years, Share-based Compensation stood at $800000.0 in 2022, then slumped by 63.88% to $289000.0 in 2024, then slumped by 99.65% to $1000.0 in 2025.
• Per Business Quant data, the three most recent Share-based Compensation figures were $1000.0 in Q4 2025, $39000.0 in Q3 2025, and $8000.0 in Q2 2025.